Macure Pharma ApS: public contracts won without a rival in Finland: 3 uncontested awards; 50% of its awards; 3 without a competition; 0 single bid.
Assay record ASY-FI-1Q2T0D2099 · Cite as: Assay Systems, “Macure Pharma ApS: public contracts won without a rival in Finland”, https://assay-systems.com/register/fi/uncontested/s/macure-pharma-aps/
Macure Pharma ApS won 3 of its 6 public contract awards in Finland without a rival from 2024-03-08 to 2026-09-08: 3 without a competition and 0 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest Pohjois-Pohjanmaan hyvinvointialue with 2.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Pohjois-Pohjanmaan hyvinvointialue gave Macure Pharma ApS 4 awards: 2 without a competition, 0 after a competition with a single bid. First 2024-03-08, latest 2026-09-08.
Sansia Oy gave Macure Pharma ApS 2 awards: 1 without a competition, 0 after a competition with a single bid. First 2024-04-12, latest 2024-08-09.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2026-01-30 | Pohjois-Pohjanmaan hyvinvointialue 70548-2026 | No competition neg-wo-call | technical |
| 2026-01-30 | Pohjois-Pohjanmaan hyvinvointialue 70257-2026 | No competition neg-wo-call | technical |
| 2024-08-09 | Sansia Oy 481261-2024 | No competition neg-wo-call | unsuitable |
Every uncontested award in Finland · All countries · Macure Pharma ApS in the register
Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.